<DOC>
	<DOCNO>NCT01250314</DOCNO>
	<brief_summary>Rational : Osteoporosis men responsible one third fragility fracture . However definition especially determinants fracture human less well know woman . Primary Objective : To search radiologic , biochemical , genetic micro-architecture bone factor associate fracture men low bone density . Study design : case/control study ( fracture vs. fracture ) men select accord low bone density ( Z-score &lt; -2 ) . Eligibility criterion : Included subject men whose age ³ 40 £ 70 year Z-score &lt; -2 least one 3 measure site ( wrist , lumbar spine , femoral neck ) . Subjects secondary osteoporosis exclude ( corticosteroid treatment , hypogonadism , … ) Progress study : The recruitment two year . The study include two period , inclusion visit period 3 month achieve radiological biological examination . The subject recruit 3 rheumatology department ( LARIBOISIERE , COCHIN ) . Subjects investigate LARIBOISIERE hospital perform radiological examination biological sample laboratory test within 3 month enrollment . Evaluation criterion : Biochemistry : dosage sexual steroid , bone remodel marker homocysteine ; Genetic : evaluation polymorphism candidate gene associate fragility fracture ( collagen type I , homocysteine , LRP5 ) ; Radiology : evaluation bone micro-architecture scan lumbar spine hip peripheral micro-scan ( XTREME sSCANCO ) bone densitometry spine , femoral neck wrist . Duration participation : follow Total duration study : 2 year 3 month . Number subject : 100 patient fracture 100 control without fracture</brief_summary>
	<brief_title>Radiological Biological Genetic Micro-architectural Bone Determinants Fractures Men With Low Bone Mineral Density</brief_title>
	<detailed_description>Statistical Analysis : Relationship compute scan parameter different site , bone micro-architectural parameter ( peripheral scan ) , biological parameter , genetic marker occurrence fracture analyze initially univariate analysis ( screen process ) . This help reduce number variable analyze second stage analysis ( i.e . multivariate analysis ) . Expected result : This study help evaluate radiological , biochemical genetic determinant bone quality men decrease bone density . It help establish prospective study evaluate predictive factor fracture men .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Subject masculine gender Aged ≥ 40 year ≤ 70 year Subject Zscore &lt; 2 least one 3 sit one 3 site ( wrist , lumbar spine ( define least 2 continuous evaluable vertebra L1L4 ) femoral neck ) discover incidentally Subject sign informed consent form The inclusion densitometry examination , less 6 month old , perform Lunar Hologic system . The reference data French reference data include Lunar system TK Hologic system ) . Exclusion criterion : Patient control subject affiliation health national system ( beneficiary cobeneficiary ) Subject receive corticoid treatment 3 month along Subject know seropositivity HIV Subject chronic inflammation disease ( rheumatoid polyarthritis , ankylose spondylarthritis , inflammatory bowel ) Subject secondary osteoporosis document clinical biological examination ( serum calcium , serum phosphate , serum phosphatase alkaline , gamma GT , testosterone ) order eliminate chronic alcoholism , alcoholic cirrhosis , hypogonadism , osteomalacia , hemochromatosis , hyperthyroidism , primitive hyperparathyroidism , hypercorticism Subject receive treatment bisphosphonates intravenously Subject receive treatment bisphosphonates ( Actonel® Fosamax® ) least 5 year stop since less 2 year Subject receive treatment bisphosphonates least 3 year stop since less 1 year Subject receive treatment bisphosphonates 6 month inclusion</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>men</keyword>
	<keyword>bone micro-architecture</keyword>
	<keyword>bone marker</keyword>
</DOC>